Earnings ·
Nano-X Imaging reported Q2 2026 revenues of $4.2 million, up 37% year-over-year, driven by the consolidation of Nanox…
NNOXNano-X Imaging Ltd.
Nano-X Imaging reported Q2 2026 revenues of $4.2 million, up 37% year-over-year, driven by the consolidation of Nanox Health IT which contributed $0.9 million. The company recorded a $40.7 million non-cash impairment charge on AI solutions intangible assets, resulting in a GAAP net loss of $55.5 million compared to $14.7 million in Q2 2025. Cash and cash equivalents declined to $31.4 million from $60.0 million at year-end. Post-quarter, the company raised $8.5 million through a registered-direct offering and ATM program. Additionally, Nano-X announced a restructuring of its South Korea operations involving a 67% workforce reduction to generate approximately $2 million in annual cost savings starting in 2027. A class action securities lawsuit was filed on June 12, 2026, with no accrual recorded due to the early stage of proceedings. Nano-X Imaging operates in the medical imaging technology industry, providing digital X-ray hardware, AI-based diagnostic solutions, and teleradiology services.